⌘K
Loading ticker…
Creative Medical Technology Holdings, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Creative Medical Technology Holdings, Inc. Common Stock (CELZ) has a 3-month relative strength percentile of 7 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 33. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.2%, relative volume 7.24×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
7 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CELZ appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $42K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $42K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CELZ Jan avg: 17.68% median: 19.28% win: 75% σ: 23.94% n: 4 2022-04-12 → 2026-05-29 | CELZ Feb avg: 13.32% median: 2.44% win: 50% σ: 31.09% n: 4 2022-04-12 → 2026-05-29 | CELZ Mar avg: -7.39% median: 0.77% win: 50% σ: 36.21% n: 4 2022-04-12 → 2026-05-29 | CELZ Apr avg: -4.53% median: -4.61% win: 40% σ: 26.83% n: 5 2022-04-12 → 2026-05-29 | CELZ May avg: -11.96% median: -2.03% win: 20% σ: 22.72% n: 5 2022-04-12 → 2026-05-29 | CELZ Jun avg: -6.80% median: -15.03% win: 25% σ: 19.20% n: 4 2022-04-12 → 2026-05-29 (current) | CELZ Jul avg: 3.14% median: 1.79% win: 50% σ: 12.11% n: 4 2022-04-12 → 2026-05-29 | CELZ Aug avg: -1.24% median: -2.69% win: 50% σ: 11.95% n: 4 2022-04-12 → 2026-05-29 | CELZ Sep avg: -9.84% median: -3.56% win: 50% σ: 19.45% n: 4 2022-04-12 → 2026-05-29 | CELZ Oct avg: 3.93% median: -3.54% win: 25% σ: 20.07% n: 4 2022-04-12 → 2026-05-29 | CELZ Nov avg: -13.52% median: -9.91% win: 25% σ: 16.24% n: 4 2022-04-12 → 2026-05-29 | CELZ Dec avg: -10.97% median: -10.17% win: 25% σ: 12.84% n: 4 2022-04-12 → 2026-05-29 |